Physician

Mark Harold Passarella, MD

According to 2025 Medicare claims, Mark Passarella, MD (NPI: 1841279445) practices urology in the Charlottesville, VA market, with the plurality of this provider's patient population coming from Greene, VA. This provider's primary affiliated billing organization is UROLOGICAL ASSOCIATES, LTD (NPI: 1700810397; TIN: 540892025) and primary practice location at 22911-8607.

Passarella's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,179 traditional Medicare patients, billed 12,226 HCPCS/CPT codes, and received $365,128 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,778 prescription claims across 402 beneficiaries totaling $271,907 in drug costs, led by Orgovyx (Relugolix). DME data shows 75 claims. Open Payments data shows 72 records totaling $2,543. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $275,425 and ending at $365,128. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $117,400 to $271,907. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $401 to $1,118.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$261K$521K2015 Medicare payment: $275,425 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $296,708 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $456,885 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $392,654 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $387,983 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $260,143 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $356,616 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $521,222 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $338,707 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $365,128 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201572814,751$275,425
20168429,844$296,708
20179328,738$456,885
201887910,275$392,654
20199629,613$387,983
20201,06810,738$260,143
20211,27511,568$356,616
20221,21213,861$521,222
20231,2809,238$338,707
20241,17912,226$365,128

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$156K$312K2015 Drug cost: $117,400 (USD; Tot_Drug_Cst)2016 Drug cost: $145,468 (USD; Tot_Drug_Cst)2017 Drug cost: $147,422 (USD; Tot_Drug_Cst)2018 Drug cost: $121,047 (USD; Tot_Drug_Cst)2019 Drug cost: $169,272 (USD; Tot_Drug_Cst)2020 Drug cost: $311,660 (USD; Tot_Drug_Cst)2021 Drug cost: $298,443 (USD; Tot_Drug_Cst)2022 Drug cost: $180,267 (USD; Tot_Drug_Cst)2023 Drug cost: $129,742 (USD; Tot_Drug_Cst)2024 Drug cost: $271,907 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015258975$117,400
20162701,164$145,468
20173011,373$147,422
20182851,329$121,047
20192931,222$169,272
20203391,358$311,660
20213791,536$298,443
20223591,421$180,267
20233461,548$129,742
20244021,778$271,907

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$29K$57K2015 Medicare payment: $26,544 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $38,762 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $31,364 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $34,684 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $50,046 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $50,779 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $52,346 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $42,790 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $57,366 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $51,202 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R78$26,544
2016N/R99$38,762
2017N/R89$31,364
2018N/R61$34,684
20191186$50,046
2020N/R98$50,779
2021N/R90$52,346
2022N/R83$42,790
20231192$57,366
2024N/R75$51,202

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more8411,267$92
84153Psa (prostate specific antigen) measurement, total511735$18
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's589662$13
36415Insertion of needle into vein for collection of blood sample552799$9
81001Manual urinalysis test with examination using microscope, automated8971,324$3

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OrgovyxRelugolix29868$75,999
MyrbetriqMirabegron753,681$53,791
Tamsulosin HclTamsulosin Hcl57344,831$8,444
DutasterideDutasteride30218,661$7,590
Tolterodine Tartrate ErTolterodine Tartrate231,110$4,595

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A4352Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), eachNN/R43$42,873
A4351Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), eachNN/R20$7,832
A4357Bedside drainage bag, day or night, with or without anti-reflux device, with or without tube, eachNN/R12$497

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.72$2,543Axonics, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Mark Harold Passarella, MD?

Tedicare shows public-source Medicare data for Mark Harold Passarella, MD (NPI 1841279445), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark Harold Passarella, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mark Harold Passarella, MD?

Mark Harold Passarella, MD is linked to UROLOGICAL ASSOCIATES, LTD (billing NPI 1700810397) in the available physician profile data.

Does Mark Harold Passarella, MD have Open Payments data?

Mark Harold Passarella, MD has 72 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.